Epidemiology of drug-resistant tuberculosis in Texas

American Journal of Epidemiology

Volumn 149, Issue 4, 1999, Pages 359-365

  Taylor, Jeffery Paul ^a,b   Bergmire Sweat, David ^a   Suarez, Lucina ^a  

^a TEXAS DEPARTMENT OF STATE HEALTH SERVICES   (United States)

^b Department of Health ^*  (United States)

Author keywords

Drug resistance; Risk factors; Tuberculosis

Indexed keywords

ISONIAZID; RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; RISK ASSESSMENT; RISK FACTOR; TUBERCULOSIS; UNITED STATES;

EID: 0033557808     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009821     Document Type: Article

References (23)

1. Ellner JJ, Hinman AR, Dooley SW, et al. Tuberculosis symposium: emerging problems and promise. J Infect Dis 1993; 168:537-51.
2. Initial therapy for tuberculosis in the era of multidrug resistance: recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1993;42:l-8.
3. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986:133:423-30.
4. Mahmoudi A, Iseman MD. Pitfalls in the care of patients with tuberculosis: common errors and their association with the acquisition of drug resistance. JAMA 1993;270:65-8.
5. Iseman MD, Madsen LA. Drug-resistant tuberculosis. Clin Chest Med 1989;10:341-53.
6. Goble M, Iseman MD, Madsen LA, et al. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin. N Engl J Med 1993:328:527-32.
7. Frieden TR, Sterling T, Pablos-Mendez A, et al. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
8. Bloch AB, Cauthen GM, Onorato IM, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994:271:665-71.
9. Moore M, Onorato IM, McCray E, et al. Trends in drugresistant tuberculosis in the United States, 1993-1996. JAMA 1997;278:833-7.
10. Pearson ML, Jereb JA, Frieden TR, et al. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis: a risk to patients and health care workers. Ann Intern Med 1992; 117:191-6.
11. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to staff and HIV-infected patients. JAMA 1992;268:1280-6.
12. Sepkowitz KA, Telzak EE, Recalde S, et al. Trends in the susceptibility of tuberculosis in New York City, 1987-1991. New York City Area Tuberculosis Working Group. Clin Infect Dis 1994:18:755-9.
13. Shafer RW, Chirgwin KD, Glatt AE, et al. HIV prevalence, immunosuppression, and drug resistance in patients with tuberculosis in an area endemic for AIDS. AIDS 1991:5:399-405.
14. Grandes G, Lopez-de-Munain J, Diaz T, et al. Drug-resistant tuberculosis in Puerto Rico, 1987-1990. Am Rev Respir Dis 1993;148:6-9.
15. Tuberculosis morbidity-United States, 1994. MMWR Morb Mortal Wkly Rep 1995;44:387-389, 395.
16. Kopanoff DE, Kilburn JO, Glassroth JL, et al. A continuing survey of tuberculosis primary drug resistance in the United States: March 1975 to November 1977. Am Rev Respir Dis 1978;118:835-42.
17. Fujiwara PI, Cook SV, Rutherford CM, et al. A continuing survey of drug-resistant tuberculosis, New York City, April 1994. Arch Intern Med 1997;157:531-6.
18. Gordin FM, Nelson ET, Matts JP, et al. The impact of human immunodeficiency virus infection on drug-resistant tuberculosis. Am J Respir Crit Care Med 1996;154:1478-83.
19. Carpenter JL, Obnibene AJ, Gorby E\V, et al. Antituberculosis drug resistance in South Texas. Am Rev Respir Dis 1983;128: 1055-8.
20. Ben-Dov I, Mason GR. Drug-resistance tuberculosis in a Southern California hospital: trends from 1969 to 1984. Am Rev Respir Dis 1987;135:1307-10.
21. Nolan CM, Williams DL, Cave MD, et al. Evolution of rifampin resistance in human immunodeficiency virusassociated tuberculosis. Am J Respir Crit Care Med 1995;152: 1067-71.
22. Valway SE, Greifinger RB, Papania M, et al. Multidrugresistant tuberculosis in the New York State prison system, 1990-1991. J Infect Dis 1994;179:151-6.
23. Barnes PF. The influence of epidemiologic factors on drug resistance rates in tuberculosis. Am Rev Respir Dis 1987; 136: 325-8.